|
An Important Message From CEO & President Dr. Magali Haas
Dear Friends and Colleagues,
 As I watched Marine Veteran Tristan Wimmer leap from the edge of Camelback Mountain in Phoenix, Arizona, my chest tightened for the fifth time that morning. I was watching BASE jump number five of 22, and every time he jumped, I felt the emotion behind his mission. Three Veterans completed an incredible feat on January 30th—they each BASE jumped 22 times in a single day to support our traumatic brain injury research. It was an honor to cheer them on and talk about our research, including the positive impact their efforts will have on the military community and all people suffering from brain trauma.
70% of people experience a traumatic event in their lives, according to global research surveys. From the risk of hitting your head demonstrated by the tragic death of Bob Saget, to the mental health crisis caused by Covid-19, to the devastating war in Ukraine—sometimes it may feel like we’re living in an increasingly traumatic world. But there is hope on the horizon: rapid advances in imaging, nanosensors, genetic analysis, computer science, and biomonitoring are revolutionizing our understanding of the human brain. Combining this knowledge with cutting-edge technology, we can address the devastating effects of trauma on the brain.
 At CVB, our collaborative roadmapping approach is accelerating progress toward our final destination: precision diagnostics and tailored therapeutics for brain trauma. As Brain Injury Awareness Month comes to a close this March, I’d like to highlight our traumatic brain injury (TBI) research roadmap designed to transform the clinical care model in years, not decades.
Thanks to our community of dedicated experts, we’ve advanced our understanding of TBI with our Brain Trauma Blueprint initiative. We’ve launched partnerships and published five of six anticipated reports in the Journal of Neurotrauma examining gaps in advancing precision solutions for TBI and recommending the most impactful next steps.
During the next five years, we’re coordinating action on evidence-based approaches to personalize concussion care. Our efforts in 2022 are focused on public awareness and empowering the research community:
- Building a national TBI registry that will help standardize data and improve patient outcomes
- Launching a patient health literacy campaign that will raise awareness of self-care and preventative practices
- Developing the next generation of clinical treatment guidelines that will lead to more precise injury classifications and diagnoses
- Building a global TBI Genetics Consortium that will enable us to understand the heritability risks for TBI outcomes
This year, we’re launching a $50M funding campaign to transform the way we diagnose and treat TBI. Improving the lives of people suffering from brain injuries requires a team effort. We hope you’ll join us on this journey to drive the roadmap forward.
Strength and Honor,
Magali Haas, MD, PhD
CEO & President
Cohen Veterans Bioscience
|
